codedgalaxy
@bdwajbleep
If Robert F. Kennedy Jr. leads HHS, he'll be in charge of the FDA and NIH, key players in gene-editing rules. While his nonprofit often challenges CRISPR, his own biotech investments spark curiosity about his approach.
0 reply
0 recast
0 reaction